Level C· Early human research exploring benefitsProspective StudyPubMed

Immunohistochemical Analysis of Nanofat Membrane, Solid PRF, and Stromal Vascular Fraction Gel.

Fakih-Gomez N., Nazari S., Azadi F., Pourani MR., Martin-Marfil P.

Prospective Study on Chronic Wound, Facial Rejuvenation, published in Aesthetic Plast Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Aesthetic Plast Surg (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40140087
DOI
10.1007/s00266-025-04798-9

Abstract (original English)

Platelet-rich fibrin (PRF) and nanofat have emerged as promising autologous biomaterials in tissue regeneration and facial rejuvenation. Both serve as vehicles for cellular growth factors that promote wound healing and tissue remodeling. This study aims to investigate the presence of endothelial and stem cell markers in nanofat membranes through immunohistochemical analysis. Eleven patients (nine women, two men) with a mean age of 36.82 ± 5.79 were included in this case-series study. Tissue samples were obtained using a mixture of nanofat and injectable PRF, with two different concentration ratios (2:1 and 1:1), in addition to solid PRF and stromal vascular fraction (SVF) gel membrane for comparison. The samples were fixed in 10% formaldehyde, processed into paraffin blocks, and sectioned (2-5 μm). Immunohistochemical staining was performed using markers CD31 (endothelial cells), CD34 (hematopoietic and adipose-derived stem cells, and endothelial cells), CD163 (macrophages), ERG (endothelial marker), S100 (adipocyte marker), and CD10 (adipose-derived stem cells). Histopathologic examination evaluated endothelial and stem cell presence as well as macrophage infiltration. Histopathological analysis revealed fragmented adipose tissue with vascular proliferation, as well as platelet and fibrin deposition. Immunohistochemical staining showed the presence of endothelial markers (CD31

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansFemaleMaleImmunohistochemistryAdultPlatelet-Rich FibrinStromal Vascular FractionAdipose TissueMiddle AgedGels

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research